Get started
Author

Heba Ibrahim Hamed

Observed names: Heba Hamed, Heba I. Hamed, HebaI Hamed
ORCID: 0000-0001-5053-1342
Observed ORCID: 0000-0001-5053-1342
OpenAlex ID: A5023122234
Assessment of oxLDL, anti-oxLDL antibodies and lipoprotein-associated phospholipase A2 as cardiovascular risk markers in obese adolescents with and without T1DM
2017 · Nesreen N. Omar, Mohamed H. EL Hefnawy, et al. · Bulletin of Faculty of Pharmacy Cairo University  · 9
Oxidative stress markers as early predictors of diabetes complications in Type 2 diabetic patients
2022 · Arwa Abdel-Raheem, Heba Ibrahim Hamed, et al. · Indian Journal of Physiology and Pharmacology · 8
Role of nitric oxide in prevention diabetic nephropathy in females after menopause
2022 · Arwa Ahmed Abdel-Raheem, Heba Ibrahim Hamed, et al. · GSC Biological and Pharmaceutical Sciences · 1
PDF
KNG-1, HSPG and Robo4 reflect hypertension-driven subclinical renal alterations and provide incremental diagnostic value in type 2 diabetic nephropathy
2026 · Heba Ibrahim Hamed, Ashraf Ismail Amin, et al. · Scientific Reports
PDF
Combined Circulating microRNA and Inflammatory Cytokine Profiles Improve Disease-Stage Discrimination of Charcot Foot in Egyptian Patients with Type 2 Diabetes Mellitus
2026 · Heba Ibrahim Hamed, Ihab Nabil Amin, et al. · Biomedicines
PDF
Serum retinol binding protein-4 and the risk of hypothyroidism in Egyptian diabetic patients with cardiovascular manifestations
2022 · Hanan A. Sleem, Heba I. Hamed, et al. · International Journal of Health Sciences
PDF
Adipokines at the crossroad between obesity and type 2 diabetes mellitus
2019 · Sahar A. Ali, Ahmed M.A. Akabawy, et al. · International Journal of Clinical Biochemistry and Research
The Cardio - Protective "paraoxonase - 1" as a Valuable Promising Tool in Diagnosis And/or Assessment of Cardiovascular Risk in Type 2 Diabetes
2018 · AhmedMA Akabawy, HebaI Hamed, et al. · International Journal of Advanced Research
PDF
Works count: 8
Citation count: 18
H-index: 2
I10-index:
Year
Topic
Type